Drug Patent Expirations for Sep 14, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION (fexofenadine hydrochloride; pseudoephedrine hydrochloride)
Sanofi Aventis Us
Patent number: 6,037,353
Expiration Date: Sep 14, 2017

ALLEGRA (fexofenadine hydrochloride)
Sanofi Aventis Us
Patent number: 6,037,353
Expiration Date: Sep 14, 2017

ALLEGRA ALLERGY (fexofenadine hydrochloride)
Sanofi Aventis Us
Patent number: 6,037,353
Expiration Date: Sep 14, 2017

ALLEGRA HIVES (fexofenadine hydrochloride)
Sanofi Aventis Us
Patent number: 6,037,353
Expiration Date: Sep 14, 2017

CHILDREN’S ALLEGRA ALLERGY (fexofenadine hydrochloride)
Sanofi Aventis Us
Patent number: 6,037,353
Expiration Date: Sep 14, 2017

CHILDREN’S ALLEGRA HIVES (fexofenadine hydrochloride)
Sanofi Aventis Us
Patent number: 6,037,353
Expiration Date: Sep 14, 2017

ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION (fexofenadine hydrochloride; pseudoephedrine hydrochloride)
Sanofi Aventis Us
Patent number: 6,037,353
Expiration Date: Sep 14, 2017

LOPROX (ciclopirox)
Medicis
Patent number: 8,227,490
Expiration Date: Sep 16, 2017

LOPROX (ciclopirox)
Medicis
Patent number: 7,981,909
Expiration Date: Sep 16, 2017

PAXIL (paroxetine hydrochloride)
Apotex Technologies
Patent number: 6,121,291
Expiration Date: Sep 17, 2017

PAXIL CR (paroxetine hydrochloride)
Apotex Technologies
Patent number: 6,121,291
Expiration Date: Sep 17, 2017

DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.

For more information try a trial


This post was originally published on this site
Comments are closed.